Skip to main content
Premium Trial:

Request an Annual Quote

David Franz, Margaret Hamburg, Stephen Albert Johnson, Scott Lillibridge, C J Peters, Peter Ehrenheim, Anthony Martin

Premium

Invitrogen created an advisory board last week for its biodefense research unit. David Franz, the chief biological scientist at Midwest Research Institute in Frederick, Md; and director of the National Agricultural Biosecurity Center at Kansas State University was appointed chairman. Those appointed as directors of the advisory board were: Margaret Hamburg, the vice president of biological programs of the Washington, D.C.-based Nuclear Threat Initiative; Stephen Albert Johnson, director of the Center for Biomedical Inventions based in Dallas; Scott Lillibridge, director for the Center for Biosecurity and Public Health Preparedness, based in Houston; and C J Peters, the director of Biodefense at the University of Texas Medical Branch Center for Biodefense and Emerging Infectious Diseases, based in Galveston, Texas.


GE Healthcare Biosciences has named Peter Ehrenheim president of protein separations, a role he initially assumed for Amersham in 1999. Ehrenheim has served as vice president for North American manufacturing for Amersham Pharmacia Biotech. He holds an MSc in mechanical engineering from the Royal Institute of Technology in Stockholm, Sweden.


Anthony Martin has been appointed to the board of directors of Windsor, Conn.-based Protedyne. Martin previously served as chairman and CEO of Molecular Probes.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.